Search research articles
Contact Us
Filters
Showing results (431-440 of 941) with videos related to
Page
of 95
Sort By:
Plant Science : an International Journal of Experimental Plant Biology
|
August 13, 2025
Silencing microRNA172 delays fruit ripening in apple (Malus domestica) through an AP2-ERF transcriptional regulation mechanism
Bin Xia, Jinquan Feng, Yarong Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 16, 2012
Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer
Virginie Baylot, Maria Katsogiannou, Claudia Andrieu, et al.
Molecular and Cellular Biology
|
February 16, 2006
The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase
Matthew J Martin, Nataliya Melnyk, Michelle Pollard, et al.
Breast Cancer Research : BCR
|
December 15, 2007
Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity
Maximino Redondo, Teresa Téllez, Maria J Roldan, et al.
Der Urologe. Ausg. A
|
August 2, 2008
[Oncolytic vesicular stomatitis viruses as intravesical agents against non-muscle-invasive bladder cancer]
B A Hadaschik, K Zhang, A I So, et al.
Molecular Cancer Therapeutics
|
October 1, 2014
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer
Naokazu Ibuki, Mazyar Ghaffari, Hadas Reuveni, et al.
The Prostate
|
February 19, 2010
Inhibition of DHCR24/seladin-1 impairs cellular homeostasis in prostate cancer
Marie-Claude Battista, Marie-Odile Guimond, Claude Roberge, et al.
Journal of the National Cancer Institute
|
September 8, 2005
A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer
Kim N Chi, Elizabeth Eisenhauer, Ladan Fazli, et al.
BJU International
|
May 15, 2004
Protein kinase C-alpha in prostate cancer
M Lahn, K Sundell, M Gleave, et al.
BJU International
|
November 15, 2008
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy
Clement Mugabe, Boris A Hadaschik, Rajesh K Kainthan, et al.
Page
of 95
Search research articles
Search
Showing results (431-440 of 941) with videos related to
Sort By:
Page
of 95
Plant Science : an International Journal of Experimental Plant Biology
|
August 13, 2025
Silencing microRNA172 delays fruit ripening in apple (Malus domestica) through an AP2-ERF transcriptional regulation mechanism
Bin Xia, Jinquan Feng, Yarong Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 16, 2012
Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer
Virginie Baylot, Maria Katsogiannou, Claudia Andrieu, et al.
Molecular and Cellular Biology
|
February 16, 2006
The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase
Matthew J Martin, Nataliya Melnyk, Michelle Pollard, et al.
Breast Cancer Research : BCR
|
December 15, 2007
Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity
Maximino Redondo, Teresa Téllez, Maria J Roldan, et al.
Der Urologe. Ausg. A
|
August 2, 2008
[Oncolytic vesicular stomatitis viruses as intravesical agents against non-muscle-invasive bladder cancer]
B A Hadaschik, K Zhang, A I So, et al.
Molecular Cancer Therapeutics
|
October 1, 2014
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer
Naokazu Ibuki, Mazyar Ghaffari, Hadas Reuveni, et al.
The Prostate
|
February 19, 2010
Inhibition of DHCR24/seladin-1 impairs cellular homeostasis in prostate cancer
Marie-Claude Battista, Marie-Odile Guimond, Claude Roberge, et al.
Journal of the National Cancer Institute
|
September 8, 2005
A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer
Kim N Chi, Elizabeth Eisenhauer, Ladan Fazli, et al.
BJU International
|
May 15, 2004
Protein kinase C-alpha in prostate cancer
M Lahn, K Sundell, M Gleave, et al.
BJU International
|
November 15, 2008
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy
Clement Mugabe, Boris A Hadaschik, Rajesh K Kainthan, et al.
Page
of 95